Equity Overview
Price & Market Data
Price: $5.00
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,151,045,632
Daily Volume: 0
Performance Metrics
1 Week: -37.50%
1 Month: -37.50%
3 Months: -44.44%
6 Months: -44.44%
1 Year: -75.00%
YTD: -41.18%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.